From inflammation to lowering levels of the virus itself, a current study hopes to demystify pot's benefits for those living with HIV.
For too long, conducting legitimate research on the medical benefits of marijuana was all but impossible.
Kept out of the hands of doctors and scientists by an overzealous DEA, pot is still classified by the federal government as a Schedule I drug under the Controlled Substances Act—the strictest category available.
This makes funding and access to research-grade, federally legal cannabis hard to come by; even in states where marijuana is legal, studies on the drug are still subject to approval by multiple boards, and samples must be procured from the only lab in the country approved to dispense research-grade marijuana.
Click here to read the complete article
Steven Blum ~ Vice.com ~
